Understand the source comparison
Side Effect Profiles: Sexual Dysfunction vs Peptide Tolerance
Lexapro's most documented adverse events. Sexual dysfunction (affecting 40–65% of patients), weight gain (mean 2–4kg over six months), and emotional blunting. Are direct pharmacological consequences of chronic SERT inhibition. Elevated synaptic serotonin at 5-
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Lexapro's most documented adverse events. Sexual dysfunction (affecting 40–65% of patients), weight gain (mean 2–4kg over six months), and emotional blunting. Are direct pharmacological consequences of chronic SERT inhibition. Elevated synaptic serotonin at 5-HT2 and 5-HT3 receptors produces the sexual side effects; serotonin's role in satiety signalling and insulin sensitivity contributes to metabolic changes. These aren't rare reactions. They're mechanistically expected outcomes of prolonged serotonergic modulation.
- Selank produces minimal documented adverse events in published research. The most common reported effect is transient nasal irritation from intranasal administration. Not a pharmacological side effect but a delivery method artefact. No sexual dysfunction has been documented because selank doesn't interact with serotonin receptors that mediate libido and arousal. No weight gain patterns emerge because the peptide doesn't alter insulin sensitivity or leptin signalling. The trade-off is peptide-specific: some users report mild sedation at higher doses, likely secondary to enhanced GABAergic tone.
- Discontinuation profiles differ dramatically. Lexapro cessation after prolonged use (more than eight weeks) frequently triggers SSRI discontinuation syndrome. Brain zaps, dizziness, irritability, insomnia. As serotonin transporter density renormalises. The syndrome can persist for weeks. Selank carries no documented discontinuation syndrome because it doesn't force adaptive receptor changes. Stop administering it and GABA-A receptor expression returns to baseline without rebound anxiety or withdrawal symptoms.
- Our experience working with research protocols involving both compounds: SSRI side effects are predictable and dose-dependent; selank's side effect profile is minimal but the peptide's short duration of action requires multiple daily administrations to maintain effect. The decision isn't 'which is safer'. It's whether you prioritise avoiding sexual and metabolic side effects (favouring selank) or prefer once-daily dosing with weeks-long stability (favouring Lexapro).